Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy. - Wikidata - awgldk - TriplyDB

Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy.

Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy.

http://www.wikidata.org/entity/Q37447171

about

Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.Neuroimmune mechanisms in Krabbe's disease Mesenchymal Stem Cells Yield Transient Improvements in Motor Function in an Infant Rhesus Macaque with Severe Early-Onset Krabbe Disease.Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse.Common and uncommon pathogenic cascades in lysosomal storage diseases Experimental therapies in the murine model of globoid cell leukodystrophy.Effect of vitamin D3 intake on the onset of disease in a murine model of human Krabbe disease.Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy.Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease.Anti-inflammatory Therapy With Simvastatin Improves Neuroinflammation and CNS Function in a Mouse Model of Metachromatic Leukodystrophy Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology A microglial hypothesis of globoid cell leukodystrophy pathology.Myelin lesions associated with lysosomal and peroxisomal disorders.Emerging therapies for neurodegenerative lysosomal storage disorders - from concept to reality.Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: Understanding pathogenesis and chances for treatment.Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.Treatment for Krabbe's disease: Finding the combination.Perspective on innovative therapies for globoid cell leukodystrophy.Neuroimmune regulation of neurophysiology in the cerebellum.Inflammatory status of transmigrating primary rat monocytes in a novel perfusion model simulating blood flow.Region- and age-dependent alterations of glial-neuronal metabolic interactions correlate with CNS pathology in a mouse model of globoid cell leukodystrophy.Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.Long-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe's Disease after Global Gene Therapy.A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel mutants

P2860

Q27309955-52CA4146-1FF8-45E1-A2E4-CBEEFC62FCB5 Q28079115-99B01581-E30E-47EB-B3F5-2ECB2BD17887 Q33722223-A73CFB89-445F-4CCB-8A7C-2A568116B926 Q33886270-2AABBC75-DF09-497D-8A22-E94CB814A428 Q33966917-AC44043A-7801-41F6-8D22-B20598B5CE89 Q34439689-BE92AC8B-20FC-4BCE-B2A1-AEC3B463E23E Q34543595-4AC3ED82-D566-4700-A1CC-7C348DDEFE78 Q34765786-30B1868D-E6DA-423D-B01F-7E8E5011DA1B Q34912498-12FEFF06-E6C6-43EE-A6A5-3708E90B3528 Q35515608-E94FE4D3-6480-49F3-86FF-10DDE311D44B Q35590505-A79C9C93-891D-44F9-9469-F541478DC611 Q36141625-28098004-CFB2-4DB2-8124-8E458C8A336A Q36401067-8A6BA89C-82AC-467C-B3B1-E02450E6AD00 Q36756813-28401652-866F-47CC-9FD5-9D243E7E43D5 Q36757186-3E7F0292-5FD2-4158-94EA-F1A1B0396F61 Q37078839-A13FBF71-3385-4428-A976-A0A4C7FC282B Q37244151-367A2899-F272-4325-B431-D421054F0962 Q37265497-9B77EF64-B939-4392-8844-C465EF6F34EB Q37785556-1874750E-A1A5-47AA-84E2-3A53BAECB3A8 Q37876354-CD58BE37-472C-4B87-87DB-0148F5D4CC0A Q38751654-9A3AACD6-DFFC-41E4-A4BF-EEA4A19F9023 Q38957246-A2D3A127-935C-4B07-98FA-0B542DAAD5E1 Q38957263-A89E1803-EB53-426F-AD2C-24F4A1BABE9D Q38957277-36A608FF-A7BC-41AA-981D-36C35EFDF5CE Q40321265-A6A3A976-93E9-4D70-AACE-6ADC1E76014C Q40402921-2DACBFA4-2BF2-4443-BE19-244233D03CDD Q41900447-601303FF-3FD5-4287-94A3-2BBA01A07654 Q42927941-6512A9D6-5A9D-4F59-BB44-0E01F9A29741 Q50056656-03007230-216A-4CB0-BC4F-4CD2A2822302 Q58741545-46A1C03A-EAE9-47B5-B434-72A1BC97E32A

P2860

Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy.

http://www.wikidata.org/entity/Q37447171

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of treatments on infla ...... h globoid cell leukodystrophy.

@en

Effects of treatments on infla ...... h globoid cell leukodystrophy.

@nl

type

label

Effects of treatments on infla ...... h globoid cell leukodystrophy.

@en

Effects of treatments on infla ...... h globoid cell leukodystrophy.

@nl

prefLabel

Effects of treatments on infla ...... h globoid cell leukodystrophy.

@en

Effects of treatments on infla ...... h globoid cell leukodystrophy.

@nl

P1433

Q37447171-717A03E8-49AB-4F77-A388-80615078CC2E

P1476

Q37447171-B409E996-3E11-4437-8026-F0EB59C2BC78

P2093

Q37447171-12A1D0C4-3890-4B71-81D8-C3EE30D161F3

Q37447171-1D0FDBA8-2C6B-4EAD-86CA-E6DF23884575

Q37447171-4CD8398C-62CC-417C-9B1F-9A156B35A734

Q37447171-E7BBC822-B9BC-4A23-9F7B-A25C7DF095F0

Q37447171-EE5B9B25-50DF-48F2-AFF2-B06D48B8CD85

Q37447171-F7430691-679A-4904-978F-5CF148C54EB9

P2860

Q37447171-18A82351-5741-490C-8A9A-EBBF420E3760

Q37447171-19545BB3-DC26-463E-B755-71CED278678F

Q37447171-1FC0BD3E-8B72-479A-AA3F-38E48EF8CD3C

Q37447171-21A5634E-3821-48CD-942B-F1DC6B607694

Q37447171-2CB255FB-31C4-4606-8FF2-96F70BAF15CA

Q37447171-37398D50-5BAA-447E-903B-FE65FD2EA918

Q37447171-42E37B7A-5FF3-4C0B-B6B5-68F6A0426AA3

Q37447171-44565A18-8974-442C-8AC2-0E7414099CA2

Q37447171-4E457DF1-B2AA-4E14-938E-D0858FC62EE3

Q37447171-51F13AE2-323E-40D0-B5EB-86FB8E8AFDBA

P304

Q37447171-6DDD8739-0266-4375-8905-A65909E6FC2D

P31

Q37447171-F2F12B4B-7F28-4C44-8124-3A58FC54189D

P356

Q37447171-CF6ECDB1-EB4A-4A8A-AE46-86DA802B3836

P407

Q37447171-44CB3FBD-096F-4D92-A124-02D883DC9EF5

P478

Q37447171-CD5BE764-86DD-46B5-B2F9-828E2BFDB004

P577

Q37447171-DDCE72A3-BD65-439B-9ACD-42FB0B2D4502

P5875

Q37447171-64EE1502-2996-475C-885F-441DDC14B356

P698

Q37447171-81F2C217-2970-4DDB-AF12-6D49B19C1DC7

P921

Q37447171-3587C3BC-4085-4625-80BD-8C3362F3095E

Q37447171-BF9F4F9C-E4AF-4035-BB15-CD137F464314

P932

Q37447171-5480E422-399D-414B-93B0-47E85277A8B2

P356

J.BRAINRES.2009.09.017

P1433

P1476

Effects of treatments on infla ...... h globoid cell leukodystrophy.

@en

P2093

D Craig Hooper

http://www.w3.org/2001/XMLSchema#string

David A Wenger

http://www.w3.org/2001/XMLSchema#string

Mark Curtis

http://www.w3.org/2001/XMLSchema#string

Mohammad A Rafi

http://www.w3.org/2001/XMLSchema#string

Paola Luzi

http://www.w3.org/2001/XMLSchema#string

Ronnie M Abraham

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model

The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity

NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin

Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease.

Are animal models useful for understanding the pathophysiology of lysosomal storage disease?

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

Clinical potential of minocycline for neurodegenerative disorders.

Storage solutions: treating lysosomal disorders of the brain.

Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.

P304

146-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BRAINRES.2009.09.017

http://www.w3.org/2001/XMLSchema#string

P407

P478

1300

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26806725

http://www.w3.org/2001/XMLSchema#string

P698

19748497

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2785448

http://www.w3.org/2001/XMLSchema#string